XRTX ▲ +15.7% - XORTX Therapeutics Inc. $XRTX - XORTX Announces Initiation of Clinical and Commercial Manufacturing of XORLO™ XORTX Therapeutics rose 15.7% following its announcement that it has initiated clinical and commercial manufacturing of XORLO, a key step toward bringing the drug candidate closer to potential market availability. The company's move to establish manufacturing capabilities typically signals progress in development and readiness for regulatory submissions or supply for clinical trials. 10-SEP-2026 04:06 PM ET